Please answer questions 1.1 and 1.2 the first 2 images are sources.

22;23;24 2023 Read the articles below and answer Question 1, Question 2 and Question 3 as follows: Article 1: Biotech Africa Specialists in recombinant protein production \& bioprocessing Driven by the global requirement for improved in vitro diagnostics. Our current range of highly purified recombinant proteins are used in the manufacture of diagnostic test kits for point of care rapid diagnostics, and research institutions. We offer a variety of protein expression platforms along with a host of other protein services, including protein refolding and structural biology analysis. With our proprietary technology, we are able to deliver highly stable and functionally active recombinant proteins. Our range of highly purified recombinant proteins are used in the manufacture of diagnostic test kits for point of care rapid diagnostics, and by research institutions. - SARS-CoV-2 proteins - Typhoid proteins - HIV proteins - Dengue proteins - Syphilis proteins - Zika proteins - Hepatitis C proteins We proudly boast: - ISO13485 certification (The first of its kind in Africa) - Proprietary technology, facilitating the delivery of recombinant proteins in native functional conformations. - Customised protein design and delivery services - Local \& international customer base (testimonials) - End-user support-assistance with applications including assay design, optimisation and protein conjugation Protein Services: We produce and deliver exceptional quality by maintaining and adhering to ISO13485 Standards and strict Quality Management Systems. - Protein Identification - Gene Design \& Optimisation (1) The Independent Institute of Education (Pty) Ltd 2023 Page 3 of 7 22; 23; 24 2023 - Subcloning, Mapping \& Sequencing - Cell Transformation \& Expression - Pilot Scale Production - Purification - Stability Studies - Optimisation of Expression - Commercial Scale Production Adapted from Source: BioTechAfrica. 2021. About Us. [Online]. Available at: https://www.biotechafrica.com/about-us [Accessed 18 February 2022]. Article 2: Local biotech company seeks government support, as it launches new Covid-19 testing technology that will allow for affordable mass testing Cape Town-based Biotech Africa is launching a new testing platform that will allow for the ultra-high throughput of Covid-19 tests, at a fraction of the current testing costs. This is in response to the shortage of test kits in South Africa, which has resulted in only around three and a half million tests having been conducted in a population of close to 60 million. "South Africa has the fifth highest number of Covid- 19 cases in the world, but only around 5% of our total population has been tested to date. The current testing capacity is around 30,000 tests a day by the state, which is simply not enough for a population the size of ours," says Paul Anley, BioTech Africa CEO. BioTech Africa's new testing technology will allow for up to 50,000 tests to be conducted every day, with potential for additional capacity of 200,000 tests to be added later if required. About BioTech Africa BioTech Africa are specialists in recombinant protein production and bioprocessing. Driven by the global requirement for improved in vitro diagnostics, their current range of highly purified recombinant proteins are used in the manufacture of diagnostic test kits for point of care rapid diagnostics, and research institutions. They offer a variety of protein expression platforms along with a host of other protein services, including protein refolding and structural biology analysis. (1) The Independent Institute of Education (Pty) Ltd 2023 Page 4 of 7 (1) The Independent Institute of Education (Pty) Ltd 2023